Stéphane Bancel (Endpoints at JPM20)
Moderna calibrates final Covid-19 vaccine efficacy at 94.1% — and today it's gunning for the EUA
Nearly a year ago, as the coronavirus emerged in China, the NIH and four major companies bet on an unproven genetic technology as the best …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
